Back to Newsroom

Medovex Corporation Initiates Forward Integration-Direct Sales Operations Strategy on Heels of Initial Strong Sales Opportunity in Key German Market

ATLANTA, GA — (Marketwired) — 09/14/17 — Medovex Corp. (NASDAQ: MDVX) (“Medovex” or the “Company”), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to back pain, today announced that it has formed a direct Medovex sales operation in Germany with a direct sales force. This new sales structure which will allow it to go direct in Germany, a large key market opportunity that has seen strong initial sales interest, and offers great dedicated reimbursement.